Abstract
The formation of a thrombus (commonly referred to as a blood clot) can potentially pose a severe health risk to an individual, particularly when a thrombus is large enough to impede blood flow. If an individual is considered to be at risk for forming a thrombus, he/she may be prophylactically treated with anticoagulant medication such as warfarin. When an individual is treated with warfarin, a blood test that measures clotting times must be performed. The test yields a number known as the International Normalized Ratio (INR). The INR test must be performed on an individual on a regular basis (e.g., monthly) to ensure that warfarin’s anticoagulation action is targeted appropriately. In this work, we explore the conditions under which an injury-induced thrombus may form in vivo even when the in vitro test shows the appropriate level of anticoagulation action by warfarin. We extend previous models to describe the in vitro clotting time test, as well as thrombus formation in vivo with warfarin treatments. We present numerical simulations that compare scenarios in which warfarin doses and flow rates are modified within biological ranges. Our results indicate that traditional INR measurements may not accurately reflect in vivo clotting times.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Prothrombin time. http://www.nlm.nih.gov/medlineplus/ency/article/003652.htm. Accessed: 2014-07-23
Warfarin INR targets. http://www.globalrph.com/warfarin_inr_targets.htm. Accessed: 2014-07-23
Antovic, J.P., Blombäck, M.: Essential Guide to Blood Coagulation. Wiley Online Library (2013)
Chang, C.H., Wang, Y.W., Yeh Liu, P.Y., Kao Yang, Y.H.: A practical approach to minimize the interaction of dietary vitamin K with warfarin. Journal of Clinical Pharmacy and Therapeutics 39, 56–60 (2014)
Fogelson, A.L., Hussain, Y.H., Leiderman, K.: Blood clot formation under flow: the importance of factor XI depends strongly on platelet count. Biophysical Journal 102(1), 10–18 (2012)
Fogelson, A.L., Tania, N.: Coagulation under flow: The influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb 34, 91–108 (2005)
Furie, B., Bouchard, B.A., Furie, B.C.: Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood 93(6), 1798–1808 (1999)
Garcia, D., Libby, E., Crowther, M.A.: The new oral anticoagulants. Blood 115(1), 15–20 (2010)
Hillyer, C.D., Abrams, C.S., Shaz, B.H., Roshal, M., Zimring, J.C., Abshire, T.C.: Transfusion medicine and hemostasis: clinical and laboratory aspects. Elsevier (2009)
Horsti, J.: Prothrombin time: evaluation of determination methods. Tampere University Press (2002)
Kitchen, S., Olson, J.D., Preston, F.E.: Quality in laboratory hemostasis and thrombosis. John Wiley & Sons (2013)
Kogan, A.E., Kardakov, D.V., Khanin, M.A.: Analysis of the activated partial thromboplastin time test using mathematical modeling. Thrombosis Research 101(4), 299–310 (2001)
Kuharsky, A.L., Fogelson, A.L.: Surface-mediated control of blood coagulation: The role of binding site densities and platelet deposition. Biophysical Journal 80, 1050–1074 (2001)
Leiderman, K., Fogelson, A.L.: Grow with the flow: a spatialtemporal model of platelet deposition and blood coagulation under flow. Mathematical Medicine and Biology 28, 47–84 (2011)
Lowe, G.: Virchow’s triad revisited: abnormal flow. Pathophysiology of Haemostasis and Thrombosis 33(5-6), 455–457 (2002)
Wajima, T., Isbister, G., Duffull, S.: A comprehensive model for the humoral coagulation network in humans. Clinical Pharmacology & Therapeutics 86(3), 290–298 (2009)
Wolberg, A.S.: Thrombin generation and fibrin clot structure. Blood Rev. 21(3), 131–142 (2007)
Xu, Z., Chen, N., Kamocka, M.M., Rosen, E.D., Alber, M.: A multiscale model of thrombus development. Journal of the Royal Society Interface 5, 705–722 (2008)
Acknowledgements
The work described in this chapter is a result of a collaboration made possible by the IMA’s workshop on WhAM! A Research Collaboration Workshop for Women in Applied Mathematics: Dynamical Systems with Applications to Biology and Medicine, and we would like to thank the IMA for its support. The authors would also like to thank Professor Aaron Fogelson (University of Utah) for generously providing Fortran codes and Professor Karin Leiderman (UC-Merced) for useful insights, in addition to Professor Stephen Duffull and Dr. Jim Faed of the University of Otago for helpful discussions. E.J. Graham gratefully acknowledges support from the National Science Foundation, DMS 0946431. K. Hood gratefully acknowledges partial support from the National Science Foundation, DGE 1144087. A. Radunskaya gratefully acknowledges partial support from the National Science Foundation, DMS 1016136. J. Simons gratefully acknowledges partial support from the National Science Foundation, DMS 104626.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Below is the link to the electronic supplementary material.
MovieFig1c (2,405 KB)
MovieFig1d (2,901 KB)
MovieFig1e (11,419 KB)
MovieFig1f (11,410 KB)
MovieFig1g (12,373 KB)
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media, LLC
About this paper
Cite this paper
dePillis, L., Graham, E.J., Hood, K., Ma, Y., Radunskaya, A., Simons, J. (2015). Injury-Initiated Clot Formation Under Flow: A Mathematical Model with Warfarin Treatment. In: Jackson, T., Radunskaya, A. (eds) Applications of Dynamical Systems in Biology and Medicine. The IMA Volumes in Mathematics and its Applications, vol 158. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2782-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2782-1_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2781-4
Online ISBN: 978-1-4939-2782-1
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)